Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients

22 Dec 2003

Abstract excerpt

Cervical cancer is the principal cause of death due to cancer in women. Five-year survival rate ranges from 15-80%, depending on the extent of the disease. New predictive markers for relapse may increase survival rates by improving treatment of patients at high risk for relapse. The gene products of CDH1 and CDH13, namely E-cadherin and H-cadherin, play a key role in cell-cell adhesion. Inactivation of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Endometrial and Cervical Cancer Treatments
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 14750164
DOI: 10.1002/ijc.11706

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patientsPMID 14750164Read ↗

Clinical Relevance of CDH1 and CDH13 DNA-Methylation in Serum of Cervical Cancer PatientsSemantic proximity Read ↗

A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis.Semantic proximity Read ↗

Methylation pattern of CDH1 promoter and its association with CDH1 gene expression in cytological cervical specimensSemantic proximity Read ↗

Clinical Significance of CDH13 Promoter Methylation in Serum Samples from Patients with Bladder Transitional Cell CarcinomaSemantic proximity Read ↗

Aberrant Methylation of CDH13 is a Potential Biomarker for Predicting the Recurrence and Progression of Non Muscle Invasive Bladder CancerSemantic proximity Read ↗

Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factorsSemantic proximity Read ↗

Hypermethylation of E‐cadherin is an independent predictor of improved survival in head and neck squamous cell carcinomaSemantic proximity Read ↗

Global methylation silencing of clustered <i>proto‐cadherin</i> genes in cervical cancer: serving as diagnostic markers comparable to HPVSemantic proximity Read ↗

Clinical and prognostic effects ofCDKN2A,CDKN2BandCDH13promoter methylation in ovarian cancer: a study using meta-analysis and TCGA dataSemantic proximity Read ↗

Cadherin-13, a Mediator of Calcium-Dependent Cell-Cell Adhesion, Is Silenced by Methylation in Chronic Myeloid Leukemia and Correlates With Pretreatment Risk Profile and Cytogenetic Response to Interferon AlfaSemantic proximity Read ↗

Loss of Expression and Aberrant Methylation of the CDH1 (E-cadherin) Gene in Breast Cancer Patients from KashmirSemantic proximity Read ↗

Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.